OAM
ABBV icon

Oppenheimer Asset Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$33.6M Buy
181,214
+3,574
+2% +$663K 0.39% 60
2025
Q1
$37.2M Sell
177,640
-6,609
-4% -$1.38M 0.46% 42
2024
Q4
$32.7M Sell
184,249
-22,638
-11% -$4.02M 0.4% 55
2024
Q3
$40.9M Buy
206,887
+2,917
+1% +$576K 0.49% 41
2024
Q2
$35M Buy
203,970
+52,731
+35% +$9.04M 0.45% 46
2024
Q1
$27.5M Sell
151,239
-9,295
-6% -$1.69M 0.4% 50
2023
Q4
$24.9M Buy
160,534
+6,542
+4% +$1.01M 0.35% 57
2023
Q3
$23M Buy
153,992
+8,437
+6% +$1.26M 0.35% 59
2023
Q2
$19.6M Sell
145,555
-11,952
-8% -$1.61M 0.29% 75
2023
Q1
$25.1M Buy
157,507
+4,215
+3% +$672K 0.39% 57
2022
Q4
$24.8M Buy
153,292
+7,652
+5% +$1.24M 0.4% 60
2022
Q3
$19.5M Buy
145,640
+10,345
+8% +$1.39M 0.34% 68
2022
Q2
$20.7M Buy
135,295
+1,897
+1% +$291K 0.35% 67
2022
Q1
$21.6M Sell
133,398
-24,766
-16% -$4.01M 0.31% 77
2021
Q4
$21.4M Sell
158,164
-509
-0.3% -$68.9K 0.28% 84
2021
Q3
$17.1M Buy
158,673
+4,393
+3% +$474K 0.24% 93
2021
Q2
$17.4M Buy
154,280
+19,286
+14% +$2.17M 0.25% 90
2021
Q1
$14.6M Buy
134,994
+9,754
+8% +$1.06M 0.23% 106
2020
Q4
$13.4M Buy
125,240
+2,068
+2% +$222K 0.22% 110
2020
Q3
$10.8M Buy
123,172
+13,055
+12% +$1.14M 0.21% 122
2020
Q2
$10.8M Buy
110,117
+8,580
+8% +$842K 0.22% 113
2020
Q1
$7.74M Sell
101,537
-21,058
-17% -$1.6M 0.19% 129
2019
Q4
$10.9M Sell
122,595
-214
-0.2% -$18.9K 0.23% 106
2019
Q3
$9.3M Sell
122,809
-5,764
-4% -$436K 0.21% 125
2019
Q2
$9.35M Buy
128,573
+51,430
+67% +$3.74M 0.21% 114
2019
Q1
$6.22M Sell
77,143
-11,565
-13% -$932K 0.14% 182
2018
Q4
$8.18M Sell
88,708
-3,998
-4% -$369K 0.2% 114
2018
Q3
$8.77M Sell
92,706
-2,076
-2% -$196K 0.19% 132
2018
Q2
$8.78M Sell
94,782
-2,392
-2% -$222K 0.21% 115
2018
Q1
$9.2M Buy
97,174
+730
+0.8% +$69.1K 0.23% 108
2017
Q4
$8.57M Hold
96,444
0.23% 117
2017
Q3
$8.57M Sell
96,444
-58,479
-38% -$5.2M 0.22% 119
2017
Q2
$11.2M Sell
154,923
-10,209
-6% -$740K 0.31% 78
2017
Q1
$10.8M Buy
+165,132
New +$10.8M 0.31% 80